MyOme

Menlo Park, CA · Founded 2017 · Privately Held (backing)

Developer of a genetic testing technology designed to provide comprehensive health insights through whole genome sequencing. MyOme is based in Menlo Park, CA and was founded in 2017. Its last reported valuation was $187 million in Dec 2025. It has raised $99.9 million.

Last reported valuation
$186.5M
Oct 2026
Priced at
—
Total raised
$99.9M
Last round
—

Who backs MyOme?

13 investors
InvestorType
Sequoia CapitalVenture capital
Founders FundVenture capital
Samsung NEXT VenturesVenture capital
NorwestVenture capital
HOF CapitalVenture capital
SoftBank Group—
Foresite CapitalVenture capital
Mayo Clinic PlatformOther
Alexandria Real Estate Equities—
Healthcare Venture Partners—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MyOme investors

13 investors are on record for MyOme, including Sequoia Capital, Founders Fund, Samsung NEXT Ventures and Norwest. By type, the record holds 6 venture capital firms.

Free account
More of MyOme with a free account
  • ·The complete investor list: 13 names
  • ·Watch MyOme: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like MyOme. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View